Despite NAD+ levels declining with age and being implicated in reduced skin elasticity, human trials for oral NAD+ boosters show mixed or null results for tangible benefits, casting doubt on the efficacy of topical applications. NAD+ is a fundamental coenzyme whose decline is linked to aging hallmarks, yet current human studies on NAD+ augmentation consistently report mixed or null effects on measurable benefits. The beauty and skincare market appears poised to capitalize on the idea of NAD+ benefits, likely outstripping rigorous scientific validation and leading to a proliferation of products with uncertain real-world impact.
Declining NAD+ levels directly impact skin health, manifesting as reduced elasticity and impaired production of vital proteins like collagen and elastin. These changes visibly contribute to the aging process, alongside increased inflammation, according to Wired. This direct link to visible aging makes NAD+ a compelling target for the beauty industry, eager to offer solutions. However, the industry's rapid adoption of NAD+-based products for anti-aging remains a speculative gamble, especially since even systemic NAD+ boosters have yet to prove consistent, tangible benefits in human trials, as reported by SupplySide Supplement Journal.
The Ubiquitous Role of NAD+ in Aging
- NAD+ levels decline significantly with age. This reduction is implicated in several hallmarks of aging, including mitochondrial dysfunction, cognitive decline, and reduced physical endurance, according to SupplySide Supplement Journal.
The pervasive role of NAD+ in cellular health means its age-related reduction contributes to multiple facets of aging beyond just skin. This widespread biological impact positions NAD+ as an attractive target for comprehensive anti-aging strategies, despite the ongoing challenges in proving tangible human benefits.
Why NAD+ Levels Plummet with Age
Low-grade chronic inflammation, often associated with aging, directly contributes to reduced NAD+ levels within the body. This inflammatory state is frequently driven by the senescence-associated secretory phenotype (SASP), a complex biological process. These interconnected processes reveal how the aging environment actively depletes NAD+, creating a complex challenge for restoration.
